Transformation-associated Epstein-Barr virus antigens as targets for immune attack.

about

Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells.Case report: a diagnostically challenging conjunctival mass caused by the Epstein-Barr virus.The ecology and pathology of Epstein-Barr virus.

P2860

Q33263443-7E46EBB4-0FE1-411F-BB73-03C2F1254834 Q40961905-9D016266-F0B0-4A98-BAFA-05F3D31DAE01 Q41036904-36714D0A-47A0-4CC7-8DEC-FFB7B93A8517

P2860

Transformation-associated Epstein-Barr virus antigens as targets for immune attack.

Item

http://www.wikidata.org/entity/Q40489821

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年学术文章

@wuu

1993年学术文章

@zh-cn

1993年学术文章

@zh-hans

1993年学术文章

@zh-my

1993年学术文章

@zh-sg

1993年學術文章

@yue

1993年學術文章

@zh

1993年學術文章

@zh-hant

name

Transformation-associated Epstein-Barr virus antigens as targets for immune attack.

@en

type

Item

label

Transformation-associated Epstein-Barr virus antigens as targets for immune attack.

@en

prefLabel

Transformation-associated Epstein-Barr virus antigens as targets for immune attack.

@en

P1476

Transformation-associated Epstein-Barr virus antigens as targets for immune attack.

@en

P2093

Gavioli R

http://www.w3.org/2001/XMLSchema#string

Trivedi P

http://www.w3.org/2001/XMLSchema#string

Zhang QJ

http://www.w3.org/2001/XMLSchema#string

P2860

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.

Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.

Release of infectious Epstein-Barr virus by transformed marmoset leukocytes

An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins.

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.

Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.

P304

86-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.1993.TB43999.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

690

http://www.w3.org/2001/XMLSchema#string

P50

Riccardo Dolcetti

Pedro O de Campos-Lima

Maria Masucci

P577

1993-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7690218

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

Transformation-associated Epstein-Barr virus antigens as targets for immune attack.

about

P2860

P2860

Transformation-associated Epstein-Barr virus antigens as targets for immune attack.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921